85 related articles for article (PubMed ID: 23321632)
1. Targeted prostate biopsies for a histogram of the index lesion.
Ukimura O; Gill IS
Curr Opin Urol; 2013 Mar; 23(2):118-22. PubMed ID: 23321632
[TBL] [Abstract][Full Text] [Related]
2. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
3. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of cognitive MRI-targeted biopsy in hitting prostate cancer-positive regions of interest.
Cerantola Y; Haberer E; Torres J; Alameldin M; Aronson S; Levental M; Bladou F; Anidjar M
World J Urol; 2016 Jan; 34(1):75-82. PubMed ID: 25981403
[TBL] [Abstract][Full Text] [Related]
5. Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping.
Belas O; Hupertan V; Comperat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
Can J Urol; 2012 Aug; 19(4):6366-72. PubMed ID: 22892260
[TBL] [Abstract][Full Text] [Related]
6. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
8. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
9. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
Obek C; Louis P; Civantos F; Soloway MS
J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
[TBL] [Abstract][Full Text] [Related]
10. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
11. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
[TBL] [Abstract][Full Text] [Related]
12. How to select the right patients for focal therapy of prostate cancer?
Passoni NM; Polascik TJ
Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
[TBL] [Abstract][Full Text] [Related]
13. Is Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Ready for "Prime Time"?
Loeb S
Eur Urol; 2015 Jul; 68(1):20-1. PubMed ID: 25465339
[No Abstract] [Full Text] [Related]
14. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
Epstein JI
J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
[TBL] [Abstract][Full Text] [Related]
15. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
Cupp MR; Bostwick DG; Myers RP; Oesterling JE
J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976
[TBL] [Abstract][Full Text] [Related]
16. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach.
Andriole GL; Bullock TL; Belani JS; Traxel E; Yan Y; Bostwick DG; Humphrey PA
Urology; 2007 Dec; 70(6 Suppl):22-6. PubMed ID: 18194707
[TBL] [Abstract][Full Text] [Related]
17. Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
Haarer CF; Gopalan A; Tickoo SK; Scardino PT; Eastham JA; Reuter VE; Fine SW
J Urol; 2009 Oct; 182(4):1337-41. PubMed ID: 19683261
[TBL] [Abstract][Full Text] [Related]
18. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies.
Delongchamps NB; Peyromaure M; Schull A; Beuvon F; Bouazza N; Flam T; Zerbib M; Muradyan N; Legman P; Cornud F
J Urol; 2013 Feb; 189(2):493-9. PubMed ID: 22982424
[TBL] [Abstract][Full Text] [Related]
19. Is it possible to predict low-volume and insignificant prostate cancer by core needle biopsies?
Berg KD; Toft BG; Røder MA; Brasso K; Vainer B; Iversen P
APMIS; 2013 Apr; 121(4):257-65. PubMed ID: 23030402
[TBL] [Abstract][Full Text] [Related]
20. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
